Every recall we track for Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. — 4 in all — plus the complaints and injury reports the public filed about them.
Otsuka recalls Abilify 30mg tablets (NDC 59148-011-13) due to cross contamination risk. Affected lots: APS00423A (exp 07/31/2025) and APS00222A (exp 11/30/2024).
Otsuka recalls Abilify 5mg tablets (NDC 59148-007-13) due to cross contamination risk. Affected lots expire 01/31/2026 or 02/28/2025. Check your bottle label for lot numbers.
Otsuka recalls 15mg Abilify tablets (NDC 59148-009-13) due to cross contamination risk. Affected lots may contain harmful substances from other products.
